IRCT20200105046010N5尚未招募未知
In- Vivo Bioequivalence study of Linagliptin / Metformin tablet 2.5/1000mg ABIDI (Liroprim 2.5/1000mg) with brand drugs (TRAJENTA® Duo 2.5/1000mg Boehringer Ingelheim, Gremany) in Iranian healthy volunteers.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health(liver, heart, kidney)
- •Body mass index(18-28)
- •Informed consent
- •Age(18-60)
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
尚未招募
Unknown
Bioequivalence Study of Linagliptin/Metformin 2.5/1000 mg FC. Tablets of The Test Drug (Kharazmi Pharma, Iran)IRCT20200105046010N101Kharazmi Pharmacy24
尚未招募
不适用
Study of Sitagliptine/ Metformin table In-Vivo Bioequivalence in healthy volunteersIn this study the bioequivalence of test and brand of Linagliptin tablets 5mg will evaluated..IRCT20200105046010N12Razak Pharma24
尚未招募
不适用
igagliptin tablets 5mg ABIDI Pharmaceuticals (TRAJENTA® 5mg Tab) , In- Vivo Bioequivalence in Iranian healthy volunteers.IRCT20200105046010N8Tabriz University of Medical Sciences24
招募中
Unknown
Bioequivalence study of Linagliptin/metformin 2.5/1000 mg tabletThis study is performed on healthy volunteers and drug concentration in whole blood is determined..IRCT20200623047902N38Actover Co.24
招募中
不适用
In-vivo Bioequivalence Test of Empagliflozin-Metformin tablets with brand drug (Synjardy® 25/1000 mg, Boehringer Ingelheim, Germany)Bio equivalence test.IRCT20200105046010N60Pars Darou Pharmaceutical Company24